Middle East Respiratory Syndrome: What Clinicians Need to Know

Middle East respiratory syndrome: what clinicians need to know.

A severe viral illness caused by a newly discovered coronavirus was first reported in the Middle East in 2012. The virus has since been named the Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV cases have been reported in several countries around the world in travelers from the Middle East. The illness has a high mortality rate. Limited human-to-human transmission has occurred...

Pressure ulcers: what clinicians need to know.

William T Wake, MD, fAAfP, is a Physician in the Department of Family Medicine and Department of Continuing Care at the Baldwin Park Medical Center in CA. E-mail: [email protected]. Introduction Pressure ulcer treatment is one of many aspects of patient care in which nursing care interfaces directly with clinician-provided medical services. Traditionally, the treatment of pressure ulcers ha...

Middle East respiratory syndrome.

Middle East respiratory syndrome (MERS) is a highly lethal respiratory disease caused by a novel single-stranded, positive-sense RNA betacoronavirus (MERS-CoV). Dromedary camels, hosts for MERS-CoV, are implicated in direct or indirect transmission to human beings, although the exact mode of transmission is unknown. The virus was first isolated from a patient who died from a severe respiratory ...

Impactful clinical trials of 2012: what clinicians need to know.

The results of clinical trials serve to inform cardiovascular (CV) practice. In 2012, a number of clinical trials were reported that have an immediate effect on patient management. We highlight the results of key trials in several areas: interventional cardiology, acute coronary syndromes (ACS), and pharmacologic therapy. The FREEDOM trial, which demonstrated a significant benefit on hard outco...

Drug interactions with warfarin: what clinicians need to know.